These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38697440)

  • 41. Evolutionary chemical binding similarity approach integrated with 3D-QSAR method for effective virtual screening.
    Durai P; Ko YJ; Pan CH; Park K
    BMC Bioinformatics; 2020 Jul; 21(1):309. PubMed ID: 32664863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predicting FFAR4 agonists using structure-based machine learning approach based on molecular fingerprints.
    Sherwani ZA; Tariq SS; Mushtaq M; Siddiqui AR; Nur-E-Alam M; Ahmed A; Ul-Haq Z
    Sci Rep; 2024 Apr; 14(1):9398. PubMed ID: 38658642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular insights on ABL kinase activation using tree-based machine learning models and molecular docking.
    Fernandes PO; Martins DM; de Souza Bozzi A; Martins JPA; de Moraes AH; Maltarollo VG
    Mol Divers; 2021 Aug; 25(3):1301-1314. PubMed ID: 34191245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacophore-based virtual screening, molecular docking and molecular dynamics studies for the discovery of novel neuraminidase inhibitors.
    Lotfi B; Mebarka O; Khan SU; Htar TT
    J Biomol Struct Dyn; 2024 Jul; 42(10):5308-5320. PubMed ID: 37334701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An integrated molecular modeling approach for in silico design of new tetracyclic derivatives as ALK inhibitors.
    Peddi SR; Sivan SK; Manga V
    J Recept Signal Transduct Res; 2016 Oct; 36(5):488-504. PubMed ID: 26758803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation.
    He Q; Han C; Li G; Guo H; Wang Y; Hu Y; Lin Z; Wang Y
    Comput Biol Chem; 2020 Oct; 88():107328. PubMed ID: 32688011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Computational design of new protein kinase D 1 (PKD1) inhibitors: homology-based active site prediction, energy-optimized pharmacophore, docking and database screening.
    Nalini ; Chadha N; Bahia MS; Kaur M; Bahadur R; Silakari O
    Mol Divers; 2018 Feb; 22(1):47-56. PubMed ID: 29058231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virtual screening of B-Raf kinase inhibitors: A combination of pharmacophore modelling, molecular docking, 3D-QSAR model and binding free energy calculation studies.
    Zhang W; Qiu KX; Yu F; Xie XG; Zhang SQ; Chen YJ; Xie HD
    Comput Biol Chem; 2017 Oct; 70():186-190. PubMed ID: 28892749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploration of the structural requirements of Aurora Kinase B inhibitors by a combined QSAR, modelling and molecular simulation approach.
    Ashraf S; Ranaghan KE; Woods CJ; Mulholland AJ; Ul-Haq Z
    Sci Rep; 2021 Sep; 11(1):18707. PubMed ID: 34548506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
    Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
    J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations.
    Zhang Y; Zhang TJ; Tu S; Zhang ZH; Meng FH
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32911607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dibenzepinones, dibenzoxepines and benzosuberones based p38α MAP kinase inhibitors: Their pharmacophore modelling, 3D-QSAR and docking studies.
    Khan MF; Verma G; Alam P; Akhter M; Bakht MA; Hasan SM; Shaquiquzzaman M; Alam MM
    Comput Biol Med; 2019 Jul; 110():175-185. PubMed ID: 31173941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of novel Flt3 inhibitory chemotypes through extensive ligand-based and new structure-based pharmacophore modelling methods.
    Abutayeh RF; Taha MO
    J Mol Graph Model; 2019 May; 88():128-151. PubMed ID: 30703688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of Flavonoids as Putative ROS-1 Kinase Inhibitors Using Pharmacophore Modeling for NSCLC Therapeutics.
    Parate S; Kumar V; Hong JC; Lee KW
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33917039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Dynamics Simulations for the Identification of Spleen Tyrosine Kinase Inhibitors.
    Kumar V; Parate S; Danishuddin ; Zeb A; Singh P; Lee G; Jung TS; Lee KW; Ha MW
    Front Cell Infect Microbiol; 2022; 12():909111. PubMed ID: 35846777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. QSAR modeling, pharmacophore-based virtual screening, and ensemble docking insights into predicting potential epigallocatechin gallate (EGCG) analogs against epidermal growth factor receptor.
    Bommu UD; Konidala KK; Pabbaraju N; Yeguvapalli S
    J Recept Signal Transduct Res; 2019 Feb; 39(1):18-27. PubMed ID: 31223050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
    Tripuraneni NS; Azam MA
    J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacophore generation, atom-based 3D-QSAR and molecular dynamics simulation analyses of pyridine-3-carboxamide-6-yl-urea analogues as potential gyrase B inhibitors.
    Azam MA; Thathan J
    SAR QSAR Environ Res; 2017 Apr; 28(4):275-296. PubMed ID: 28399673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Computational investigation of imidazopyridine analogs as protein kinase B (Akt1) allosteric inhibitors by using 3D-QSAR, molecular docking and molecular dynamics simulations.
    Gu X; Wang Y; Wang M; Wang J; Li N
    J Biomol Struct Dyn; 2021 Jan; 39(1):63-78. PubMed ID: 31838955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of
    Babu TM; Rammohan A; Baki VB; Devi S; Gunasekar D; Rajendra W
    Drug Des Devel Ther; 2016; 10():3611-3632. PubMed ID: 27853354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.